fashion -WSS

fashion

author：explore 2025-09-06 06:00:05 - browse：8636

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Unique patient identifier: Experts argue the benefits, pitfalls

WSS

Global cancer cases to surge 77% by 2050, WHO report says

The Biogen Aduhelm mess could happen again

Headspace, Meta partner to launch VR meditation app for Quest

Just how do doctors, lawmakers, and the public define abortion?

Unique patient identifier: Experts argue the benefits, pitfalls

The CDC's new social media misinformation war

hotspot

fashion

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

What’s missing from the debate over nursing home staff minimums

Walensky prepares to leave CDC — and Congress — behind

Medicare Advantage plans can’t deny care with AI, CMS warns

The high cost of giving birth even with insurance

Devoted Health’s losses in Medicare Advantage persist

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What it’s like to watch children die of measles

hotspot

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Medicare Advantage plans can’t deny care with AI, CMS warns

Gene therapy for Afghan refugees’ infant will be fully covered

Precocious puberty in girls comes with mental health risks

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

RSV shot was 90% effective at preventing hospitalizations in kids

focus

explore

focus

leisure time